0001209191-20-017732.txt : 20200310 0001209191-20-017732.hdr.sgml : 20200310 20200310170020 ACCESSION NUMBER: 0001209191-20-017732 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200304 FILED AS OF DATE: 20200310 DATE AS OF CHANGE: 20200310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Throsby Mark CENTRAL INDEX KEY: 0001790357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37773 FILM NUMBER: 20702551 MAIL ADDRESS: STREET 1: C/O MERUS N.V. STREET 2: YALELAAN 62 CITY: UTRECHT STATE: P7 ZIP: 3584 CM ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merus N.V. CENTRAL INDEX KEY: 0001651311 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM BUSINESS PHONE: 31 030 253 8800 MAIL ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM FORMER COMPANY: FORMER CONFORMED NAME: Merus B.V. DATE OF NAME CHANGE: 20150819 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-04 0 0001651311 Merus N.V. MRUS 0001790357 Throsby Mark C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584 CM NETHERLANDS 0 1 0 0 EVP & Chief Scientific Officer Common Shares 2020-03-04 4 S 0 368 18.10 D 44155 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. Amount represents the weighted average price of shares sold, which ranged from $17.73 to $18.19. Details of individual transactions are available upon request. /s/ Peter Silverman as attorney-in-fact 2020-03-06